Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Premier Optics is a specialist ophthalmic company based in the United Kingdom that focuses on the distribution and supply of surgical products for eye care. The company provides a comprehensive range of intraocular lenses (IOLs), ophthalmic viscosurgical devices (OVDs), and specialized surgical instruments to both the National Health Service (NHS) and private healthcare providers. Known for its expertise in the cataract and vitreoretinal surgery markets, Premier Optics established a strong reputation for clinical support and high-quality product delivery. In October 2022, the company was acquired by Rayner, a prominent global manufacturer of IOLs, to enhance Rayner's direct service model and product portfolio within the UK. This acquisition allowed for the integration of Premier Optics' distribution network and clinical expertise into Rayner's broader ophthalmic operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Premier Optics.